Thu, March 5, 2020

Alan Carr Maintained (CDTX) at Strong Buy with Decreased Target to $120 on, Mar 5th, 2020

Alan Carr of Needham, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $200 to $120 on, Mar 5th, 2020.

Alan, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications